Seismic Therapeutic to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Seismic Therapeutic, Inc., the machine learning immunology company, today announced that company management will participate in the following investor conferences:
TD Cowen 46th Annual Health Care Conference
Date: Monday, March 2, 2026
Location: Boston, MA
Format: 1x1 meetings
Leerink Partners Global Healthcare Conference
Date: Monday, March 9, 2026
Location: Miami Beach, FL
Format: 1x1 meetings
About Seismic Therapeutic
Seismic Therapeutic™ is a clinical-stage biotechnology company making a major shift in how immunology therapies are discovered and developed, enabled by machine learning. The company has a growing preclinical stage best-in-class and first-in-class biologics pipeline, derived from its integrated IMPACT platform, to control dysregulated adaptive immunity and address multiple autoimmune diseases. The company is backed by a strong syndicate of life science investors and is located in the Boston biotechnology hub. For more information, please visit www.seismictx.com and follow us on LinkedIn and on X @Seismic_Tx.

Media Contact: Kathryn Morris The Yates Network [email protected] Investor Contact: Ami Bavishi or Nick Colangelo Gilmartin Group LLC [email protected]Source: Seismic Therapeutic
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- York Space Systems, Inc. Notice of October 30, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
- Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
- HBAR Price Prediction After 27% Rally: Hedera Tests $0.12 as Pepeto Presale Clears $11.1 Million Mark
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share